The North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period. the US accounted for the largest share of the nuclear medicine market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1108
Growth in the North American nuclear medicine market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer cardiovascular diseases and initiatives to lessen the demand-supply gap of Mo-99.
Market Segmentation
By type, the SPECT radiopharmaceutical segment is expected to account for the largest share of the diagnostic nuclear medicine market
Based on type, the North American nuclear medicine market is categorized into diagnostic and therapeutic nuclear medicine. The diagnostic nuclear medicine segment is further categorized into SPECT and PET radiopharmaceuticals. The SPECT radiopharmaceuticals segment is expected to account for the largest share of the market
By application, the PET oncology application segment is expected to account for the largest share of the market
Based on application, the North American nuclear medicine market is segmented into SPECT, PET, and therapeutic applications. The PET applications segment is further segmented into oncology, cardiology, and neurology, among others. The oncology PET application segment is projected to register the highest growth rate in the forecast period.
The US to dominate the market
The growth of this market can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the country
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1108
The prominent players in the global North American nuclear medicine market include Cardinal Health (US), GE Healthcare (US), Curium (France), Lantheus Medical Imaging (US), Bayer AG (Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), and NTP Radioisotopes (South Africa).
Report Objectives
- To define, describe, and forecast the North American nuclear medicine market on the basis of type, application, procedural volume, and country
- To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, and opportunities)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to North America (the US and Canada)
- To strategically analyze the market structure and profile key players and their core competencies in the market
Get Free Customization @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1108
